🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II/III trial studies how well daunorubicin and cytarabine with o...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2019-03-28
Trial ID
NCT03701308
This bridging study will evaluate the efficacy of uproleselan, a specific E...
Status
Terminated
Location
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2021-11-17
Trial ID
NCT05054543
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability and pharmacok...
Status
Completed
Location
Celerion
Start Date
2014-06
Trial ID
NCT02168595
The purpose of this study is to find out whether the drug uproleselan can h...
Status
Terminated
Location
The University of Michigan
Start Date
2021-11-12
Trial ID
NCT05057221
Treatments Being Tested
This study will evaluate GMI-1271, a specific E-selectin antagonist, in mul...
Status
Completed
Location
Vejle Hospital
Start Date
2016-06
Trial ID
NCT02811822
Treatments Being Tested
The investigators hypothesize that prophylactic E-selectin inhibition via a...
Status
Completed
Location
Washington University School of Medicine
Start Date
2021-05-05
Trial ID
NCT04682405
Treatments Being Tested
Phase 1, open-label, parallel, active-controlled, multiple IV dose, proof o...
Status
Completed
Location
Celerion
Start Date
2015-11
Trial ID
NCT02703051
Treatments Being Tested
This study will evaluate the safety and tolerability of uproleselan(GMI-127...
Status
Completed
Location
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2021-02-24
Trial ID
NCT04839341
Treatments Being Tested
This phase Ib/II trial finds out the best dose and effect of cladribine and...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2021-06-11
Trial ID
NCT04848974
Treatments Being Tested
This phase I trial evaluates the side effects of uproleselan, azacitidine, ...
Status
Terminated
Location
University of California Davis Comprehensive Cancer Center
Start Date
2021-07-02
Trial ID
NCT04964505
Treatments Being Tested